Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy
Related Experiment Videos
Insights
Children with epilepsy have lower levels of brain amine metabolites in cerebrospinal fluid (CSF) compared to healthy children. These differences in 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) suggest a link between brain chemistry and epilepsy.
Area of Science:
- Neurochemistry
- Pediatric Neurology
- Epilepsy Research
Background:
- Cerebrospinal fluid (CSF) analysis is crucial for understanding neurotransmitter function.
- Altered levels of brain amines, such as serotonin and dopamine metabolites, have been implicated in various neurological disorders.
- Investigating these metabolites in pediatric epilepsy is essential for uncovering potential pathophysiological mechanisms.
Purpose of the Study:
- To compare CSF concentrations of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) between children with epilepsy and healthy controls.
- To examine the relationship between CSF amine metabolite levels and probenecid concentrations.
- To identify factors potentially influencing these metabolite levels in pediatric epilepsy.
Main Methods:
- CSF samples were collected from 14 children with epilepsy and 17 age-matched controls.
- Concentrations of 5-HIAA, HVA, and probenecid were measured using established analytical techniques.
- Statistical analyses were performed to compare metabolite levels and assess correlations.
Main Results:
- CSF concentrations of 5-HIAA and HVA were significantly lower in children with epilepsy compared to controls.
- Amine metabolite concentrations were positively correlated with probenecid levels in both groups.
- These reductions were independent of age, anticonvulsant use, CSF folate, protein, or cell count.
Conclusions:
- Pediatric epilepsy is associated with reduced CSF levels of key brain amine metabolites (5-HIAA and HVA).
- The findings suggest a potential role for altered brain monoamine systems in the pathophysiology of epilepsy.
- Further research is warranted to explore the therapeutic implications of these neurochemical differences.
Abstract:
Cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and probenecid were examined in 14 children with epilepsy (ages 6 months to 17 years) and 17 controls (ages 14 months to 16 years). The concentrations of amine metabolites were significantly correlated with probenecid concentrations in both groups of children. Cerebrospinal fluid concentrations of 5-HIAA were 63.6 ng per milliliter plus or minus 8.23 S.E.M. and 117 ng per milliliter plus or minus 11.6 S.E.M. for the epilepsy and control groups respectively. HVA averaged 89.1 ng per milliliter plus or minus 15.2 S.E.M in epilepsy and 172 ng per milliliter plus or minus 19.2 S.E.M. in the control group. These findings indicate a significant difference between epilepsy and control groups. Probenecid concentrations were similar in each group. The reduced cerebrospinal fluid amine metabolite concentrations in children with epilepsy were not related to age, anticonvulsant medication, cerebrospinal fluid folate or protein concentration, or cerebrospinal fluid cell count. Our findings suggest a relationship between brain amines and epilepsy.